Abstract
The purpose of this article is to review the nature of the immune response to influenza virus both in hosts which experience natural infection, particularly man, and in hosts which are experimentally infected, particularly mice, Until recently, an article on this topic may well have contained only a rather superficial account of the properties of the virion with hardly a mention of the replication process. However, the past few years have seen great advances in two almost separate developments. On the one hand, detailed information is now available on the viral genome and the expression of viral proteins: there are complete amino acid sequences and X-ray crystallographic analysis of the two surface glycoproteins, the hemagglutinin and the neuraminidase; we have a greater understanding of the roles of gene reassortment and mutation in the generation of antigenic shift and drift, and of the mechanism of viral replication and assembly. On the other hand, and although there are still very significant gaps, there has been a great increase in our knowledge of the different classes of lymphocytes, particularly T cells, and to a lesser extent of other cell types involved in the immune response to this virus. Significant correlations in the case of human studies and the findings from cell transfer studies in experimental systems have made possible the allocation of particular roles to different cell types.
Keywords
- Influenza Virus
- Influenza Infection
- Influenza Virus Infection
- Reassortant Virus
- Influenza Virus Hemagglutinin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Preview
Unable to display preview. Download preview PDF.
References
Ada GL (to be published) The generation of cellular versus humoral immunity. In: Arnon R (ed) Synthetic vaccines. CRC, Boca Raton
Ada GL, Skehel JJ (1985) Are peptides good antigens? Nature 316:764–765
Ada GL, Yap KL (1977) Matrix protein expressed at the surface of cells infected with influenza viruses. Immunochemistry 14:643–651
Ada GL, Leung K-N, Ertl HCJ (1981) An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses. Immun Rev 58:4–24
Allen PM, Matsueda GR, Haber E, Unanue ER (1985) Specificity of the T cell receptor: two different determinants are generated by the same peptide and the IAk molecule. J Immunol 135:368–373
Anders EM, Katz JM, Jackson DC, White DO (1981) In vitro antibody response to influenza virus. II. Specificity of helper T cells recognising hemagglutinin. J Immunol 127:669–672
Andrew ME, Coupar BEH, Ada GL, Boyle DB (to be published) Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microbial Pathogenesis
Andrewes CH, Bang FB, Burnet FM (1955) A short description of the myxovirus group (influenza and related viruses). Virology 1:176–184
Andrus L, Lafferty KJ (1982) Inhibition of T cell activity by cyclosporin A. Scand J Immunol 15:449–458
Ashman RB (1982) Persistence of cell-mediated immunity to influenza A virus in mice. Immunology 47:165–168
Ashman RB, Müllbacher A (1979) A helper T-cell for anti-viral cytotoxic T cell responses. J Exp Med 150:1277–1282
Askonas BA, Webster RG (1980) Monoclonal antibodies to the haemagglutinin and to H-2 inhibit the cross reactive T cell populations induced by influenza. Eur J Immunol 10:151–156
Askonas BA, Pala P (1985) Influenza specific cytotoxic T-cell clones and immune interferon. In: Feldman M, Lamb JR, Woody NJ (eds) Human T cell clones. Humana Press, New Jersey, pp 381–388
Askonas BA, McMichael AJ, Webster RG (1982a) The immune response to influenza viruses and the problem of protection against infection. In: Beare (ed) Basic and applied influenza research. CRC, Boca Raton, pp 159–188
Askonas BA, Müllbacher A, Ashman RB (1982b) Cytotoxic T memory cells in virus infection and the specificity of helper T cells. Immunology 45:79–84
Astry CL, Yolken RH, Jakab GJ (1984) Dynamics of viral growth, viral enzymatic activity and antigenicity in murine lungs during the course of influenza pneumonia. J Med Virol 14:81–90
Atassi MZ, Webster RG (1983) Localization, synthesis and activity of an antigenic site on influenza hemagglutinin. Proc Natl Acad Sci USA 80:840–844
Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER (1985) Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:359–361
Barry RD, Ives DR, Cruikshank JG (1962) Participation of deoxyribonucleic acid in the multiplication of influenza virus. Nature 194:1139–1140
Bean WJ (1984) Correlation of influenza A virus nucleoprotein with host species. Virology 133:438-442
Becht H, Huang RTC, Fleischer B, Boschek CB, Rott R (1984) Immunologic properties of the small chain HA2 of the haemagglutinin of influenza viruses. J Gen Virol 65:173–183
Belshe RB, Van Voris LP (1984) Cold-recombinant influenza A/California/10/76(H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J Infect Dis 149:735–740
Belshe RB, Van Voris LP, Bartram J, Crookshanks FK (1984) Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis 150:834–840
Bennink JR, Yewdell JW, Gerhard W (1982) A viral polymerase involved in recognition of influenza virus infected cells by a cytotoxic T cell clone. Nature 296:75–76
Bennink JR, Yewdell JW, Smith GL, Moller C, Moss B (1984) Recombinant vaccinia virus primes and stimulates influenza haemagglutinin specific cytotoxic T cells. Nature 311:578–579
Betts RF, Douglas RG, Murphy BR (1985) Resistance to challenge with influenza A/Hong Kong/123/77(H1N1) wild-type virus induced by live attenuated A/Hong Kong/123/77(H1N1) cold-adapted reassortant virus. J Infect Dis 151:744–745
Biddison WE, Doherty PC, Webster RG (1977) Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses. J Exp Med 146:690–697
Both GW, Sleigh MJ, Cox NJ, Kendal AP (1983) Antigenic drift in influenza H3 hemagglutinin from 1968–1980. Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol 48:52–60
Braciale TJ (1977) Immunologic recognition of influenza virus-infected cells. Cell Immunol 33:423–436
Braciale TJ (1979) Specificity of cytotoxic T cells directed to influenza virus haemagglutinin. J Exp Med 149:856–869
Braciale TJ, Yap KL (1978) Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med 147:1236–1252
Braciale TJ, Andrew ME, Braciale VL (1981) Heterogeneity and specificity of cloned lines of influenza virus-specific cytotoxic T lymphocytes. J Exp Med 153:910–923
Braciale TJ, Braciale VL, Henkel TJ, Sambrook J, Gething MJ (1984) Cytotoxic T lymphocyte recognition of the influenza haemagglutinin gene product expressed by DNA mediated gene transfer. J Exp Med 159:341–354
Burlington DB, Clements ML, Meiklejohn G, Phelan M, Murphy BR (1983) Hemagglutinin specific antibody responses in immunoglobulin G, A and M isotypes as measured by ELISA after primary or secondary infection of humans with influenza A virus. Infect Immun 41:540–545
Burlington DB, Djeu JY, Wells MA, Kiley SC, Quinnan GV (1984) Large granular lymphocytes provide an accessory function in the in vitro development of influenza A virus-specific cytotoxic T cells. J Immunol 132:3154–3158
Callard RE (1979) Specific in vitro antibody response to influenza virus by human blood lymphocytes. Nature 282:734–736
Callard RE, McGaughan GW, Babbage J, Souhami RL (1982) Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells. J Immunol 129:153–156
Cambridge G, MacKenzie JS, Keast D (1976) Cell-mediated immune response to influenza virus infection in mice. Infect Immun 13:36–43
Cancro MP, Gerhard W, Klinman NR (1978) The diversity of the influenza-specific primary B-cell repertoire in Balb/c mice. J Exp Med 147:776–787
Cate TR, Mold NG (1975) Increased influenza pneumonia mortality of mice adoptively immunized with node and spleen cells sensitized by inactivated but not live virus. Infect Immun 11:908–914
Cavanagh D, Mitkis F, Sweet C, Collie MH, Smith H (1979) The localisation of influenza virus in the respiratory tract of ferrets. J Gen Virol 44:505–514
Clements ML, O’Donnell S, Levine MM, Chanock RM, Murphy BR (1983) Dose response of A/Alaska/6/77(H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect Immun 40:1044–1051
Clements ML, Betts RF, Murphy BR (1984) Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80(H3N2) wild-type virus infection. Lancet i:705–708
Clements ML, Betts RF, Murphy BR (1985) Comparison of immune responses and efficacies of inactivated and live virus vaccines. J Cell Biochem Supp 9C:284–285
Colman PM, Varghese JN, Laver WG (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41–44
Couch RB, Kasel JA (1983) Immunity to influenza in man. Ann Rev Microbiol 37:529–549
Couch RB, Kasel JA, Six HR, Cate TR (1981) The basis for immunity to influenza in man. In: Nayak (ed) Genetic variation among influenza viruses. Academic, New York, pp 535–546
Couch RB, Quarles JM, Cate TR, Zahradnik JM (1985) Field trials among college students with live attenuated influenza virus vaccines. J Cell Biochem Supp 9C:285
Cox NJ, Kendal AP (1984) Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J Infect Dis 149:194–200
Davis AR, Kostek B, Mason BB, Hsiao CL, Morin J, Dheer SK, Hung PP (1985) Expression of hepatitis B surface antigen with a recombinant adenovirus. In: Chanock P, Lerner R, Brown F (arranged) Modern approaches to vaccines. Cold Spring Harbor Laboratories, New York, p 85
Della-Porta AJ, Westaway EG (1978) A multihit model for the neutralization of animal viruses. J Gen Virol 38:1–19
DeLisi C, Berzofsky JA (1985) T cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci USA 82:7048–7052
Dennert G, Weiss S, Warner JF (1981) T cells may express multiple activities: specific allohelp, cytolysis and delayed-type hypersensitivity are expressed by a cloned T-cell line. Proc Natl Acad Sci USA 78:4540–4543
Djeu JY, Stocks N, Zoon K, Stanton GJ, Tomonen T, Heberman RB (1982) Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med 156:1222–1234
Doherty PC, Effros RB, Bennink J (1977) Heterogeneity of the cytotoxic response of thymus derived lymphocytes after immunization with influenza virus. Proc Natl Acad Sci USA 74:1209–1213
Doherty PC, Biddison WE, Bennink JR, Knowles BB (1978) Cytotoxic T cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med 148:534–543
Effros RB, Frankel ME, Gerhard W, Doherty PC (1979) Inhibition of influenza immune T cell effector function by virus specific hybridoma antibody. J Immunol 123:1343–1346
Ennis FA, Meager A (1981) Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med 154:1279–1289
Ennis FA, Meager A, Beare AS, Hua QY, Riley D, Schwarz G, Schild GC, Rook AH (1981) Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 2:891–893
Ennis FA, Rook AH, Qi Y-L, Schild GC, Riley D, Pratt R, Potter CW (1981) HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 2:887–891
Ertl HCJ, Finberg RW (1985) Induction of a virus specific immune response by an anti-idiotypic antibody. J Cell Biochem Supp 9C:294
Ettensohn DB, Roberts NJ (1984) Influenza virus infection of human alveolar and blood-derived macrophages: differences in accessory cell function and interferon production. J Infect Dis 149:942–949
Fischer A, Nash S, Beverley PCL, Feldmann M (1982) An influenza virus matrix protein-specific human T cell line with helper activity for in vitro anti-hemagglutinin antibody production. Eur J Immunol 12:844–849
Fleischer B, Becht H, Rott R (1985) Recognition of viral antigens by human influenza A virus specific T lymphocyte clones. J Immunol 135:2800–2804
Gangemi JD, Hightower JA, Jackson RA, Maker MH, Welsh MG, Sigel MM (1983) Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and non-responsive mice by Propionibacterium acnes. Infect Immun 39:726–735
Gell PGH, Benacerraf B (1959) Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs. Immunology 2:64–70
Gell PGH, Moss PAH (1985) Production of cell-mediated immune response to Herpes simplex virus by immunization with anti-idiotype heteroantisera. J Gen Virol 66:1801–1804
Geraci JR, St Aubin DJ, Barker IK, Webster RG, Hinshaw VS, Bean WJ, Ruhnke HL, Prescott JH, Early G, Baker AS, Madoff S, Schooley RT (1982) Mass mortality of harbor seals. Pneumonia associated with influenza A virus. Science 215:1129–1131
Gerhardt W, Yewdell J, Frankel ME, Webster R (1981) Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713–716
Gething M-J, Sambrook J (1982) Construction of influenza hemagglutinin genes that code for intracellular and secreted forms of the protein. Nature 300:598–660
Geyson HM, Rodda SJ, Mason TJ (1986) The delineation of peptides able to mimic assembled epitopes. In: Synthetic peptides as antigens. Pitman, London, pp 130–149
Gonchoroff NJ, Kendal AP, Phillips DJ, Reimer CB (1982) Immunoglobulin M and G antibody response to type- and subtype-specific antigens after primary and secondary exposures of mice to influenza A viruses. Infect Immun 35:510–517
Green JA, Charette RP, Yeh T-H, Smith CB (1982) Presence of interferon in acute- and convalescent-phase sera of humans with influenza or an influenza-like illness of undetermined etiology. J Infect Dis 145:837–841
Green N, Alexander H, Olson A, Alexander S, Shinnick TM, Sutcliffe JG, Lerner RA (1982) Immunogenic structure of the influenza virus hemagglutinin. Cell 28:477–487
Gresser I, Tovey MG, Maury C, Bandu MT (1976) Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with Herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J Exp Med 144:1316–1323
Haaheim LR, Schild GC (1980) Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 2. Antiviral activities of the antibodies in biological systems. Acta Path Microbiol Scand B 88:335–340
Hackett CJ, Askonas BA, Webster RG, Van Wyke K (1980) Quantitation of influenza virus antigens on infected target cells and their recognition by cross reactive cytotoxic T cells. J Exp Med 151:1014–1025
Hackett CJ, Dietzschold B, Gerhard W, Christ B, Knorr R, Gillessen D, Melchers F (1983) Influenza virus site recognised by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule. J Exp Med 158:294–302
Hall WJ, Douglas RG (1980) Pulmonary function during and after common respiratory infections. Annu Rev Med 31:233–238
Haller O (1981) Inborn resistance of mice to orthomyxoviruses. Curr Top Microbiol Immunol 92:25–52
Hashimoto G, Wright PF, Karzon DT (1983) Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis 148:785–794
Hay AJ, Lomniczi B, Bellamy AR, Skehel JJ (1977) Transcription of the influenza virus genome. Virology 83:337–355
Hicks JT, Ennis FA, Kim E, Verbonitz M (1978) The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol 121:1437–1445
Hinshaw VS, Bean WJ, Webster RG, Easterday BC (1978) The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine. Virology 84:51–62
Hodgkin PD (1985) The activation and action of T lymphocytes. PhD Thesis, Australian National University, Canberra
Hoshino A, Takenaka H, Mizukoshi O, Imonishi J, Kishida T, Tovey MG (1983) Effect of anti-interferon serum on influenza virus infection in mice. Antiviral Res 3:59–65
Hoskins TW, Davies JK, Smith AJ, Miller CL, Allchin A (1979) Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital. Lancet 1:33–35
Hruskova J, Syrucek L, Tumova B, Stumpa A, Bruckova M, Losova M, Berkovicova V (1976)
Levels of immunoglobulins and antibodies to haemagglutinin and neuraminidase of influenza virus in nasal secretions after natural infection. Acta Virol 30:126–134 Hurwitz JL, Heber-Katz E, Hackett CJ, Gerhard WJ (1984) Characterization of the murine TH response to influenza virus hemagglutinin. Evidence for three major specificities. J Immunol 133:3371–3377
Husseini RH, Sweet C, Collie MH, Smith H (1981) The relation of interferon and nonspecific inhibitors to virus levels in nasal washes of ferrets infected with influenza viruses of differing virulence. Br J Exp Pathol 62:87–93
Husseini RH, Sweet C, Collie MH, Smith H (1982) Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. J Infect Dis 145:520–524
Husseini RH, Sweet C, Overton H, Smith H (1984) Role of maternal immunity in the protection of newborn ferrets against infection with a virulent influenza virus. Immunology 52:389–394
Jackson DC, Ada GL, Hapel AJ, Dunlop MBC (1976) Changes in the surface of virus-infected cells recognised by cytotoxic T cells. II. A requirement for glycoprotein synthesis in virus-infected target cells. Scand J Immunol 5:1021–1029
Jackson DC, Murray JM, White DO, Fagan CN, Tregear GW (1982) Antigenic activity of a synthetic peptide comprising the “loop” region of influenza virus hemagglutinin. Virology 120:273–276
Kaplan DV, Braciale VL, Braciale TJ (1984) Antigen-dependent regulation of IL-2 receptor expression of cloned human cytotoxic T lymphocytes. J Immunol 133:1966–1969
Katz JM, Laver WG, White DO, Anders EM (1985) Recognition of influenza virus hemagglutinin by sub-type specific and cross reactive proliferative T cells; contribution of HA1 and HA2 polypeptide chains. J Immunol 134:616–622
Kees U, Krammer PH (1984) Most influenza A virus specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants. J Exp Med 159:365–377
Kosinowski VH, Allen H, Gething MJ, Waterfield MD, Klenk H (1980) Recognition of viral glycoproteins by influenza A specific cross reactive cytotoxic T lymphocytes. J Exp Med 151:945–958
Kris RM, Asofsky R, Evans CB, Small PA (1985) Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol 132:1230–1235
Lamb RA, Choppin PW (1983) Gene structure and replication of influenza virus. Virology 81:382–397
Lamb JR, Feldmann M (1982) A human suppressor T cell clone which recognises an autologous helper T cell clone. Nature 300:456–468
Lamb JR, Eckels DD, Lake P, Woody JN, Green N (1982) Human T cell clones recognise chemically synthesized peptides of influenza hemagglutinin. Nature 300:66–69
Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M (1983) Induction of tolerance in influenza virus-immune T-lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 157:1434–1447
Lambre CR, Thibon M, Le Maho S, Di Bella G (1983) Autoantibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase. Immunology 49:311–319
Langman RE, Cohn M (1985) T cell function via restricted recognition of antigen, not antigen-restricted recognition. Cell Immunol 94:598–608
Lanzavecchia A (1985) Antigen-specific interaction between T and B cells. Nature 314:537–539
Laver WG, Valentine RC (1969) Morphology of the isolated hemagglutinin and neuraminidase subunits of the influenza virus. Virology 38:105–119
Lee PWK, Hayes EC, Joklik WC (1981) Protein 61 is the reovirus attachment protein. Virology 108:156–163
Leung KN, Ada GL (1981a) Induction of natural killer cells during murine influenza virus infection. Immunobiol 160:342–366
Leung KN, Ada GL (1981b) The effect of helper T cells on the primary in vitro production of delayed-type hypersensitivity to influenza virus. J Exp Med 153:1029–1043
Leung K-N, Ada GL (1982) Different functions of subsets of effector T cells in murine influenza virus infection. Cell Immunol 67:312–324
Leung K-N, Schiltknecht E, Ada GL (1982) In vivo collaboration between precursor T cells and helper T cells in the development of delayed-type hypersensitivity reaction to influenza virus in mice. Scand J Immunol 16:257–264
Liew FY, Russell SM (1980) Delayed-type hypersensitivity to influenza virus. J Exp Med 151: 799–814
Liew FY, Russell SM (1983) Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza infection in mice. Nature 304:541–543
Lin YL, Askonas BA (1981) Biological properties of an influenza A virus-specific killer T cell clone. J Exp Med 154:225–234
Lukacher AE, Braciale VL, Braciale TJ (1984) In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 160:814–826
Lukacher AE, Morrison LA, Braciale VL, Malissen B, Braciale TJ (1985) Expression of specific cytolytic activity by H-2 I region-restricted, influenza specific T lymphocyte clones. J Exp Med 162:171–187
Lyons CR, Lipscomb MF (1983) Alveolar macrophages in pulmonary immune responses. I. Role in the initiation of primary immune responses and in the selective recruitment of T lymphocytes to the lung. J Immunol 130:1113–1119
Mahy BWJ, Hastie ND, Armstrong SJ (1972) Inhibition of influenza virus replication by alpha-amantin: mode of action. Proc Natl Acad Sci USA 69:1421–1424
Mak NK, Leung KN, Ada GL (1982a) The generation of “cytotoxic” macrophages in mice during infection with influenza A or Sendai virus. Scand J Immunol 15:553–561
Mak NK, Zhang Y-L, Ada GL, Tannock GA (1982b) Humoral and cellular responses of mice to infection with a cold adapted influenza A virus variant. Infect Immun 38:218–225
Mak NK, Schiltknecht E, Ada GL (1983) Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum. Cell Immunol 78:314–325
Mak NK, Sweet C, Ada GL, Tannock GA (1984) The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. Immunology 51:407–416
Manca F, Clarke JA, Miller A, Sercarz EE, Shastri N (1984) A limited region within hen egg-white lysozyme serves as the focus for a diversity of T cell clones. J Immunol 133:2075–2078
Masurel N, Ophof P, de Jong P (1981) Antibody response to immunisation with influenza A/USSR/71(H1N1) virus in young individuals primed or unprimed for A/New Jersey/76(H1N1) virus. J Hyg Camb 87:201–209
McDermott MR, Befus AD, Bienenstock J (1982) The structural basis for immunity in the respiratory tract. Int Rev Exp Pathol 23:47–112
McGaughan GW, Adams E, Basten A (1984) Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol 132:1190–1196
McLaren C, Butchko GM (1978) Regional T- and B-cell responses in influenza-infected ferrets. Infect Immun 22:189–194
McLaren C, Pope B (1980) Macrophage dependency of in vitro B cell response to influenza virus antigens. J Immunol 125:2679–2684
McMichael AJ, Ting A, Zweerink HJ, Askonas BA (1977) HLA restriction of cell mediated lysis of influenza virus-infected human cells. Nature 270:524–526
McMichael AJ, Gotch F, Eullen P, Askonas BA, Webster RG (1981) The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol 43:267–284
McMichael AJ, Gotch FM, Dongworth DW, Clark A, Potter CW (1983) Declining T-cell immunity to influenza 1977–1982. Lancet 2:762–764
McMichael AJ, Michie CA, Gotch FM, Smith GL, Moss B (to be published) Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol
Milich DR, Thornton GB, McLachlan A, McNamara MK, Chisari FV (to be published) T and B cell recognition of native and synthetic pre-S-region determinants of HBsAg. In: Chanock RM, Lerner RA, Brown F (eds) Modern approaches to vaccines. Cold Spring Harbor Laboratory, New York
Mitchell DM, Fitzharris P, Knight RA, Schild GC (1982) Kinetics of specific in vitro antibody production following influenza immunisation. Clin Exp Immunol 48:491–498
Mitchell DM, McMichael AJ, Lamb JR (1985) The immunology of influenza. Br Med Bull 41:80–85
Mizuochi T, Golding H, Rosenberg AS, Glimcher LH, Malek TK, Singer A (1985) Both L3T4+ and Lyt2+ helper T cells initiate cytotoxic T lymphocyte responses against allogeneic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med 162:427–443
Morein B, Sundquist B, Höglund S, Dalsgaard K, Osterhaus A (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308:457–560
Muller GM, Shapira M, Arnon R (1982) Anti-influenza response achieved by immunization with a synthetic conjugate. Proc Natl Acad Sci USA 79:569–573
Murphy BR, Chanock RM (1985) Immunization against viruses. In: Fields BN (ed) Virology. Raven, New York, pp 349–370
Murphy BR, Webster RG (1985) Influenza viruses. In: Fields BN, Knipe DM, Chanock RM, Melnick JL, Roizman B, Shope RE (eds) Virology. Raven, New York, pp 1179–1239
Murphy BR, Baron S, Chalhub EG, Uhlendorf CP, Chanock RM (1973) Temperature sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis 128:488–493
Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM (1982) Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun 36:1102–1108
Nayak DP, Davis AR, Ueda M, Bos TJ, Sivasubramanian N (1984) Characterization of influenza virus glycoproteins expressed from cloned cDNAs in prokaryotic and eukaryotic cells. In: Chanock RM, Lerner RA (eds) Modern approaches to vaccines. Cold Spring Harbor Laboratory, New York, pp 165–172
Nestorowicz A, Laver G, Jackson DC (1985a) Antigenic determinants of influenza virus haemagglutinin. X. A comparison of the physical and antigenic properties of monomeric and trimeric forms. J Gen Virol 65:1687–1695
Nestorowicz A, Tregear GW, Southwell CN, Martyn J, Murray JM, White DO, Jackson DC (1985b) Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites. Mol Immunol 22:145–154
Owen JA, Allouche M, Doherty PC (1982) Limiting dilution analysis of the specificity of influenzaimmune cytotoxic T cells. Cell Immunol 67:49–59
Oxford JS, Schild GC, Potter CW, Jennings R (1979) The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg Camb 82:51–61
Oxford JS, Haaheim LR, Slepushkin A, Werner J, Kuwert E, Schild GC (1981) Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunisation or natural infection. J Hyg Camb 86:17–26
Pala P, Askonas BA (1985) Induction of Kb-restricted anti-influenza cytotoxic T cells in C57B1 mice: importance of stimulator cell type and immunization route. Immunology 55:601–607
Pala P, Townsend ARM, Askonas BA (1986) Viral recognition by influenza A virus crossreactive cytotoxic T cells: the proportion of Tc that recognise nucleoprotein varies between individual mice. Eur J Immunol 16:193–198
Palese P, Kingsbury DW (eds) (1983) The genetics of influenza viruses. Springer, Vienna New York
Palese P, Ritchey MB, Schulman JL (1977) P1 and P3 proteins of influenza virus are required for complementary RNA syntheses. J Virol 21:1187–1195
Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 79:4927–4931
Perrin LH, Joseph BS, Cooper NR, Oldstone MBA (1976) Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab′)2, and the alternative complement pathway. J Exp Med 143:1027–1041
Possee RD, Schild GC, Dimmock NJ (1982) Studies on the mechanisms of neutralization of influenza virus by antibody: evidence that neutralizing antibody (antihaemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. J Gen Virol 58:373–386
Potter CW (1982) Inactivated influenza virus vaccine. In: Beare AS (ed) Basic and applied influenza research. CRC Press, Florida, pp 119–156
Puck JM, Glezen WP, Frank AL, Six HR (1980) Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 142:844–849
Reiss CS, Schulman JL (1980a) Influenza type A virus M protein expression on infected cells is responsible for cross-reactive recognition by cytotoxic thymus-derived lymphocytes. Infect Immun 29:719–723
Reiss CS, Schulman JL (1980b) Cellular immune responses of mice to influenza virus infection. Cell Immunol 56:502–509
Reiss CS, Burakoff SJ (1981) Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses. J Exp Med 154:541–546
Reuman PD, Paganini CMA, Ayoub EM, Small PA (1983) Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol 130:932–936
Rodgers BC, Mims CA (1981) Interaction of influenza virus with mouse macrophages. Infect Immun 31:751–757
Rodgers BC, Mims CA (1982a) Influenza virus replication in human alveolar macrophages. J Med Virol 9:177–184
Rodgers BC, Mims CA (1982 b) Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus. Infect Immun 36:1154–1159
Roitt IM, Thanavala YM, Male DK, Hay FC (1985) Anti-idiotypes as surrogate antigens: structural considerations. Immunol Today 6:265–267
Roizman B (1985) Multiplication of viruses: an overview. In: Fields BN et al. (eds) Virology. Raven, New York, pp 69–75
Roizman B, Jenkins FJ (1985) Genetic engineering of novel genomes of large DNA viruses. Science 229:1208–1213
Rosenthal AS, Shevach EM (1973) Function of macrophages in antigen recognition by guinea pig T lymphocytes. J Exp Med 138:1194–1212
Rosztoczy I, Sweet C, Toms GL, Smith H (1975) Replication of influenza virus in organ cultures of human and simian urogenital tissues and human foetal tissues. Br J Exp Pathol 56:322–328
Russell SM, Liew FY (1979) T cells primed by influenza virion internal components can co-operate in the antibody response to haemagglutinin. Nature 280:147–148
Scalzo AA, Anders EM (1984) Role of I-E antigens in the mitogenic response to influenza viruses. Proc Aust Soc Imm 14:93
Schiltknecht E, Ada GL (1985a) In vivo effects of cyclosporin on influenza A virus-infected mice. Cell Immunol 91:227–239
Schiltknecht E, Ada GL (1985b) The generation of effector T cells in influenza A-infected, cyclosporine A-treated mice. Cell Immunol 95:340–348
Schiltknecht E, Ada GL (1985c) Influenza virus-specific T cells fail to reduce lung virus titers in cyclosporin-treated, infected mice. Scand J Immunol 22:99–103
Schulman JL (1975) Immunology of influenza. In: Kilbourne ED (ed) Influenza viruses and influenza. Academic, New York, pp 373–393
Sela M (1969) Antigenicity: some molecular aspects. Science 166:1365–1374
Shapira M, Jibson M, Muller G, Arnon R (1984) Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Proc Natl Acad Sci USA 81:2461–2465
Shaw MW, Lamon EW, Compans RW (1981) Surface expression of a non-structural antigen on influenza A virus-infected cells. Infect Immun 34:1065–1068
Shaw MW, Lamon EW, Compans RW (1982) Immunologie studies of the influenza A virus non-structural protein NS1. J Exp Med 156:243–254
Shvartsman YS, Zykov MP (1976) Secretory anti-influenza immunity. Adv Immunol 22:291–330
Shvartsman YS, Agranovskaya EN, Zykov MP (1977) Formation of secretory and circulating antibodies after immunisation with live and inactivated influenza virus vaccines. J Infect Dis 135:697–705
Simons K, Garoff H, Helenius A (1982) How an animal virus gets into and out of its host cell. Sci Am 246:58–66
Sinickas VG, Ashman RB, Hodgkin PD, Blanden RV (1985) The cytotoxic response to murine cytomegalovirus. III. Lymphokine release and cytotoxicity are dependent upon phenotypically similar immune cell populations. J Gen Virol 66:2551–2562
Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield DM, White JM, Wilson IA, Wiley DC (1982) Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci USA 79:968–972
Smith GL, Murphy BR, Moss B (1983) Construction and characterisation of an infectious vaccinia virus recombinant that expresses the influenza haemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci USA 80:7155–7159
Stein-Streilein J, Bennett M, Mann D, Kumor V (1983) Natural killer cells in mouse lung: surface phenotype, target preference and response to local influenza virus infection. J Immunol 131:2699–2704
Sterkers G, Michon J, Henin Y, Gomard E, Hannoun C, Levy JP (1985) Fine specificity analysis of human influenza-specific cloned cell lines. Cell Immunol 94:394–405
Stitz L, Huang RTC, Hengartner H, Rott H, Zinkernagel RM (1985) Cytotoxic T cell lysis of target cells fused with liposomes containing influenza virus haemagglutinin and neuraminidase. J Gen Virol 66:1333–1339
Streicher HZ, Berkower IJ, Busch M, Gurd FRN, Berzofsky JA (1984) Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci USA 81:6831–6835
Sweet C, Smith H (1980) Pathogenicity of influenza virus. Microbiol Rev 44:303–330
Sweet C, Cavanagh D, Collie MH, Smith H (1978) Sensitivity to pyrexial temperatures: a factor contributing to virulence differences between two clones of influenza virus. Br J Exp Pathol 59:373–380
Sweet C, Macartney JC, Bird RA, Cavanagh D, Collie MH, Husseini RH, Smith H (1981) Differential distribution of virus and histological damage on the lower respiratory tract of ferrets infected with influenza viruses of differing virulence. J Gen Virol 54:103–114
Tannock GA, Paul GA (1985) Homologous and heterologous immunity to influenza A virus induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-Ca. J Cell Biochem Supp 9C:294
Tannock GA, Paul JA, Barry RD (1984) Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca and parental strains with similar surface antigens. Infect Immun 43:457–462
Tao SJ, Mak NK, Ada GL (1985) Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune responses to two H1N1 and H3N2 viruses. J Virol 53:645–650
Taylor HP, Dimmock NJ (1985a) Mechanisms of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med 161:198–209
Taylor HP, Dimmock NJ (1985b) Mechanisms of neutralization of influenza virus by IgM. J Gen Virol 66:903–907
Taylor PA, Askonas BA (1983) Diversity in the biological properties of anti-influenza cytotoxic T cell clones. Eur J Immunol 13:707–711
Taylor PM, Wraith DC, Askonas BA (1985) Control of immune interferon release by cytotoxic T-cell clones specific for influenza. Immunology 54:607–614
Thomas DB, Hackett CJ, Askonas BA (1982) Evidence for two T-helper populations with distinct specificity in the humoral response to influenza A viruses. Immunology 47:429–436
Toms GL, Davies JA, Woodward CG, Sweet C, Smith H (1977) The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence. Br J Exp Pathol 58:444–458
Townsend ARM, McMichael AJ (1985) Specificity of cytotoxic T lymphocytes stimulated with influenza virus. Prog Allergy 36:10–43
Townsend ARM, Skehel JJ (1984) The influenza virus nucleoprotein gene controls the induction of both subtype specific and cross reactive T cells. J Exp Med 160:552–563
Townsend ARM, McMichael AJ, Carter NP, Huddieston JA, Brownlee GG (1984a) Cytotoxic T cell recognition of the influenza nucleoprotein and haemagglutinin expressed in transfected mouse L cells. Cell 39:13–25
Townsend ARM, Skehel JJ, Taylor PM, Palese P (1984b) Recognition of influenza A virus nucleoprotein by an H-2 restricted cytotoxic T cell clone. Virology 133:456–459
Townsend ARM, Gotch FM, Davey J (1985) Cytotoxic T cells recognise fragments of the influenza nucleoprotein. Cell 42:457–567
Van Voorhis WC, Valnisky J, Hoffman E, Luban J, Hair LS, Steinman RN (1983) The relative efficacy of human monocytes and dendritic cells as accessory cells for T cell regulation. J Exp Med 158:174–191
Van Wyke KL, Hinshaw VS, Bean WJ, Webster RG (1980) Antigenic variation of influenza A virus nucleoprotein detected with monoclonal antibodies. J Virol 35:24–30
Van Wyke KL, Yewdell JW, Reck LJ, Murphy BR (1984) Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies. J Virol 49:248–252
Varghese JN, Laver WG, Colman PM (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9f resolution. Nature 303:35–40
Verbonitz MW, Ennis FA, Hicks JT, Albrecht P (1978) Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection. J Exp Med 147:265–270
Virelizier JL (1975) Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 115:434–439
Virelizier JL, Oxford JS, Schild GC (1976) The role of humoral immunity in host defence against influenza A infection in mice. Postgrad Med J 52:332–337
Virelizier JL, Allison A, Oxford C, Schild GC (1977) Early presence of nucleoprotein antigen on the surface of influenza virus-infected cells. Nature 266:52–53
Wabuke-Bunoti MAN, Fan DP (1983) Isolation and characterization of a CNBr cleavage peptide of influenza viral hemagglutinin stimulatory for mouse cytolytic T lymphocytes. J Immunol 130:2386–2391
Waldman RH, Wood SH, Torres EJ, Small PA (1970a) Influenza antibody response following aerosol administration of inactivated virus. Am J Epidem 91:575–584
Waldman RH, Wigley FM, Small PA (1970b) Specificity of respiratory secretion antibody against influenza virus. J Immunol 104:1477–1483
Waldman RH, Jurgensen PF, Olsen GN, Ganguly R, Johnson JE (1973) Immune responses of the human respiratory tract. I. Immunoglobulin levels and influenza virus vaccine antibody response. J Immunol 111:38–41
Waldman RH, Lazzell VA, Bergmann C, Khakoo R, Jacknowitz AI, Howard SA, Rose C (1981) Oral immunization against influenza. Trans Am Clin Climatol Assoc 93:133–140
Webster RG, Askonas BA (1980) Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 10:396–401
Webster RG, Laver WG (1980) Determination of the number of non-overlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104:139–148
Wells MA, Albrecht P, Daniel S, Ennis FA (1978) Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun 22:758–762
Wells MA, Daniel S, Djeu J, Kiley S, Ennis FA (1983) Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes. J Immunol 130:2908–2914
Welsh RM (1981) Natural cell-mediated immunity during viral infections. Curr Top Microbiol Immunol 92:83–103
White J, Helenius A, Gething MJ (1982) Haemagglutinin of influenza virus expressed from a clonal gene promoter membrane fusion. Nature 300:658–659
Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373–378
Wilson IA, Skehel JJ, Wiley DC (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3f resolution. Nature 289:366–373
Wong GHW, Clark-Lewis I, McKimm-Breschwin JL, Harris AW, Schrader JW (1983) Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage and myeloid cell lines. J Immunol 131:788–793
Wraith DC, Askonas BA (1985) Induction of influenza A virus specific cross-reactive T cells by a nucleoprotein/haemagglutinin preparation. J Gen Virol 66:1327–1331
Wright PF, Okabe N, McKee KT, Maassab HF, Karzon DT (1982) Cold-adapted reeombinant influenza A virus vaccines in seronegative young children. J Infect Dis 146:71–79
Wright PF, Murphy BR, Keruina M, Lawrence EM, Phelan MA, Karzon DT (1983) Secretory immunological response after intranasal inactivated influenza A virus vaccination: evidence for IgA memory. Infect Immun 40:1092–1095
Wyde PR, Wilson MR, Cate TR (1982) Interferon production by leucocytes infiltrating the lungs of mice during primary influenza virus infection. Infect Immun 38:1249–1255
Wylie DE, Sharman LA, Klinman NR (1982) Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells. J Exp Med 155:403–414
Yamada A, Ziese MR, Young JF, Yamada YK, Ennis FA (1985) Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J Exp Med 162:663–674
Yap KL, Ada GL (1977) Cytotoxic T cells specific for influenza virus-infected target cells. Immunology 32:151–159
Yap KL, Ada GL (1978) The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognising a common virion antigen. Scand J Immunol 8:413–420
Yap KL, Ada GL (1979) The effect of specific antibody on the generation of cytotoxic T lymphocytes and the recovery of mice from influenza virus infection. Scand J Immunol 10:325–332
Yap KL, Ada GL, McKenzie IFC (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273:238–239
Yap KL, Braciale TJ, Ada GL (1979) Role of T-cell function in recovery from murine influenza infection. Cell Immunol 43:341–351
Yarchoan R, Nelson DL (1984) Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: analysis of original antigenic sin by limiting dilution cultures. J Immunol 132:928–935
Yarchoan R, Murphy BR, Strober W, Clements ML, Nelson DL (1981) In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza. J Immunol 125:1958–1963
Yewdell JW, Frank E, Gerhardt W (1981) Expression of influenza A virus internal antigens on the surface of infected P815 cells. J Immunol 126:1814–1819
Yewdell JW, Bennink JR, Smith GL, Moss B (1985) Influenza A virus nucleoprotein is a major target antigen for cross reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 83:1785–1789
Young JF, Desselberger U, Palese P, Ferguson B, Shatzman AR, Rosenberg M (1983) Efficient expression of influenza virus NS1 non-structural proteins in Escherichia coli. Proc Natl Acad Sci USA 80:6105–6109
Zahradnik JM, Kasel JA, Martin RR, Six HR, Cate TR (1983) Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine. J Med Virol 11:227–285
Zee YC, Osebold JW, Dotson WM (1979) Antibody responses and interferon titers in the respiratory tracts of mice after aerosolised exposure to influenza virus. Infect Immun 25:202–207
Zweerink HJ, Courtneidge SA, Skehel JJ, Crumpton MJ, Askonas BA (1977) Cytotoxic T cells kill influenza virus-infected cells but do not distinguish between serologically distinct type A viruses. Nature 267:354–356
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ada, G.L., Jones, P.D. (1986). The Immune Response to Influenza Infection. In: , et al. Current Topics in Microbiology and Immunology. Current Topics in Microbiology and Immunology, vol 128. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71272-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-71272-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71274-6
Online ISBN: 978-3-642-71272-2
eBook Packages: Springer Book Archive